Notice: This CMS-approved document has been submitted - Philips ...

CMS-1403-FC
anticipate that this change will have a significant
budgetary impact on the Medicare program.
C. Payment for Covered Outpatient Drugs and Biologicals
1. ASP Issues
The changes discussed in section II.F.1. of this final
rule with comment period with respect to payment for
covered outpatient drugs and biologicals, are estimated to
have no impact on Medicare expenditures.
2. CAP Issues
In the CY 2009 PFS proposed rule, we proposed minor
refinements for the CAP, specifically the annual CAP
payment amount update mechanism, the definition of a CAP
physician, easing the restriction on the transportation of
CAP drugs between practice locations, and the dispute
resolution process. After the publication of the CY 2009
PFS proposed rule, further CAP implementation for 2009 was
postponed. At this time, we are seeking feedback about the
CAP from current and former CAP physicians, potential
vendors, and other interested parties. We will assess the
information and consider implementing changes to the CAP
before proceeding with another bid solicitation.
Our proposed refinements to the CAP are not being
finalized in this rule. Therefore, there is no potential
1052